Search - tctmd.com

Displaying 221 - 240 of 396

Sort: Relevancy | Date

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

News Daily News

Extended Low-Dose Ticagrelor May Prevent Adverse Events Post-MI, Study Finds

Yael L. Maxwell

September 12, 2017

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

News Daily News

Cardiac Testing in Chest Pain Patients Without Ischemia Does Not Reduce Acute MI Admissions

Michael O'Riordan

June 28, 2017

News Daily News

‘Mishmash’ of Troponin Cutoffs Being Used to Diagnose MI

Todd Neale

June 23, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Daily News

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

Todd Neale

April 21, 2017

News Daily News

Rapid Rule-Out Strategy With High-Sensitivity Troponin Shows Promise Ahead of US Commercial Availability of Test

L.A. McKeown

April 17, 2017

News Daily News

Physically Active Less Likely to Die After MI Than Sedentary Individuals

Michael O'Riordan

April 14, 2017

News Daily News

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Michael O'Riordan

April 11, 2017

News Conference News ACC 2017

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Daily News

Noncardiac Surgery Riskier After Incomplete vs Complete Revascularization, Observational Study Finds

Yael L. Maxwell

February 01, 2017

News Daily News

Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival

Michael O'Riordan

December 13, 2016

News Daily News

Anemia Common in ACS Patients, Linked with Higher Mortality

Michael O'Riordan

November 23, 2016

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

News Conference News AHA 2016

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Michael O'Riordan

November 15, 2016

Advertisement

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Extended Low-Dose Ticagrelor May Prevent Adverse Events Post-MI, Study Finds

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

ESC Updates Guidelines for Treating STEMI Patients

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Cardiac Testing in Chest Pain Patients Without Ischemia Does Not Reduce Acute MI Admissions

‘Mishmash’ of Troponin Cutoffs Being Used to Diagnose MI

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

Rapid Rule-Out Strategy With High-Sensitivity Troponin Shows Promise Ahead of US Commercial Availability of Test

Physically Active Less Likely to Die After MI Than Sedentary Individuals

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Noncardiac Surgery Riskier After Incomplete vs Complete Revascularization, Observational Study Finds

Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival

Anemia Common in ACS Patients, Linked with Higher Mortality

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content